• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    OXiGENE, Inc. (OXGN)

    -NasdaqCM
    1.42 Up 0.03(2.16%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.39
    Open:1.40
    Bid:1.25 x 2000
    Ask:1.49 x 300
    1y Target Est:6.25
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:1.34 - 1.45
    52wk Range:1.34 - 3.92
    Volume:376,711
    Avg Vol (3m):391,656
    Market Cap:29.46M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OXGNUp 2.16%29.46M
    AZNUp 0.43%88.51B
    SNYUp 2.40%130.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.74
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops therapeutics primarily to treat cancer. The company focuses on developing vascular disrupting agents (VDAs) that disrupt abnormal blood vessels associated with solid tumor progres... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback